Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Singulair (Montelukast Sodium) Granules, 4 mg, Merck Research NDA 21-409/S3 12/31/02 1/23/03 4/9/03 Singulair (Montelukast Sodium) Granules, Merck Research NDA 21-409 7/26/02 8/6/02 7/30/02 Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Granules, Merck Research NDA 20-829/S23 & 20-830/S26 & 21-409/S5 10/2/03 10/9/03 10/10/03 Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Granules, 10 mg, 4 & 5 mg & 4 mg, Merck Research NDA 20-829/S17 & 20-830/S20 & 21-409/S3 12/31/02 1/23/03 4/7/03 Singulair (montelukast sodium) Chewable Tablets, Merck & Co., NDA 20-829/S12 08/02/01 08/02/01 Singulair (Montelukast Sodium) Tablets, Merck Research NDA 20-829 & 20-830 2/20/98 9/10/98 12/8/98 5/24/01 Singulair (Montelukast Sodium) Tablets, 10 mg, Merck Research NDA 20-829/S001 2/12/99 7/5/01 Singulair (Montelukast Sodium) Chewable Tablets, 5 mg, Merck Research NDA 20-830/S001 2/12/99 7/5/01 Singulair (Montelukast Sodium) Chewable Tablets, 4 mg, Merck NDA 20-830/S-8 3/3/00 9/7/01 Singulair (montelukast sodium) Chewable Tablets, Merck & Co. NDA 20-830/S-011 11/23/01 11/25/02 04/24/03 Singulair Indication: prophylaxis for asthma in children 2-5 years of age. Singulair (Montelukast Sodium) Tablets & Chewable Tablets, Merck Research Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Oral Granules, Merck Research Laboratories | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Oral Granules, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Oral Granules, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Tablets, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem Corp.